Topical b-Blockers May Affect Airways Function in Elderly Patients

FEBRUARY 01, 2003

The use of topical b-blockers for the treatment of glaucoma is associated with an increased risk of airways obstruction in elderly patients, according to a report in the British Medical Journal. Researchers matched people who had used topical b-blockers with unexposed people by age and sex. An estimated 55 patients would need to be treated to cause 1 case of airways obstruction each year.

Ophthalmologists, general practitioners, physicians, and pharmacists need to be aware of the possibility of airways obstruction in patients taking topical b-blockers for glaucoma, the researchers noted. b-blockers should be discontinued immediately when a patient develops airways obstruction, and the ophthalmologist should be informed, the researchers added.

A repeat prescription that includes topical b-blockers and drugs for asthma should automatically sound an alarm, the authors concluded.


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.